LeonaBio Q2 EPS $(0.80) Beats $(1.36) Estimate
LeonaBio (NASDAQ:LONA) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.36) by 41.18 percent. This is a 55.56 percent increase over losses of $(1.80) per share from the
LeonaBio lost less money than people expected this quarter, which is a good sign. When a company that's still losing money does better than expected, it means they're heading in the right direction—like plugging a hole in a boat a little faster than planned.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.